Global Adalimumab Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Adalimumab Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Adalimumab by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Adalimumab by Country/Region, 2017, 2022 & 2028

2.2 Adalimumab Segment by Type

2.2.1 Adalimumab

2.2.2 Adalimumab Biosimilar

2.3 Adalimumab Sales by Type

2.3.1 Global Adalimumab Sales Market Share by Type (2017-2022)

2.3.2 Global Adalimumab Revenue and Market Share by Type (2017-2022)

2.3.3 Global Adalimumab Sale Price by Type (2017-2022)

2.4 Adalimumab Segment by Application

2.4.1 Adults

2.4.2 Children

2.5 Adalimumab Sales by Application

2.5.1 Global Adalimumab Sale Market Share by Application (2017-2022)

2.5.2 Global Adalimumab Revenue and Market Share by Application (2017-2022)

2.5.3 Global Adalimumab Sale Price by Application (2017-2022)

3 Global Adalimumab by Company

3.1 Global Adalimumab Breakdown Data by Company

3.1.1 Global Adalimumab Annual Sales by Company (2020-2022)

3.1.2 Global Adalimumab Sales Market Share by Company (2020-2022)

3.2 Global Adalimumab Annual Revenue by Company (2020-2022)

3.2.1 Global Adalimumab Revenue by Company (2020-2022)

3.2.2 Global Adalimumab Revenue Market Share by Company (2020-2022)

3.3 Global Adalimumab Sale Price by Company

3.4 Key Manufacturers Adalimumab Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Adalimumab Product Location Distribution

3.4.2 Players Adalimumab Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Adalimumab by Geographic Region

4.1 World Historic Adalimumab Market Size by Geographic Region (2017-2022)

4.1.1 Global Adalimumab Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Adalimumab Annual Revenue by Geographic Region

4.2 World Historic Adalimumab Market Size by Country/Region (2017-2022)

4.2.1 Global Adalimumab Annual Sales by Country/Region (2017-2022)

4.2.2 Global Adalimumab Annual Revenue by Country/Region

4.3 Americas Adalimumab Sales Growth

4.4 APAC Adalimumab Sales Growth

4.5 Europe Adalimumab Sales Growth

4.6 Middle East & Africa Adalimumab Sales Growth

5 Americas

5.1 Americas Adalimumab Sales by Country

5.1.1 Americas Adalimumab Sales by Country (2017-2022)

5.1.2 Americas Adalimumab Revenue by Country (2017-2022)

5.2 Americas Adalimumab Sales by Type

5.3 Americas Adalimumab Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Adalimumab Sales by Region

6.1.1 APAC Adalimumab Sales by Region (2017-2022)

6.1.2 APAC Adalimumab Revenue by Region (2017-2022)

6.2 APAC Adalimumab Sales by Type

6.3 APAC Adalimumab Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Adalimumab by Country

7.1.1 Europe Adalimumab Sales by Country (2017-2022)

7.1.2 Europe Adalimumab Revenue by Country (2017-2022)

7.2 Europe Adalimumab Sales by Type

7.3 Europe Adalimumab Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Adalimumab by Country

8.1.1 Middle East & Africa Adalimumab Sales by Country (2017-2022)

8.1.2 Middle East & Africa Adalimumab Revenue by Country (2017-2022)

8.2 Middle East & Africa Adalimumab Sales by Type

8.3 Middle East & Africa Adalimumab Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Adalimumab

10.3 Manufacturing Process Analysis of Adalimumab

10.4 Industry Chain Structure of Adalimumab

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Adalimumab Distributors

11.3 Adalimumab Customer

12 World Forecast Review for Adalimumab by Geographic Region

12.1 Global Adalimumab Market Size Forecast by Region

12.1.1 Global Adalimumab Forecast by Region (2023-2028)

12.1.2 Global Adalimumab Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Adalimumab Forecast by Type

12.7 Global Adalimumab Forecast by Application

13 Key Players Analysis

13.1 AbbVie

13.1.1 AbbVie Company Information

13.1.2 AbbVie Adalimumab Product Offered

13.1.3 AbbVie Adalimumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 AbbVie Main Business Overview

13.1.5 AbbVie Latest Developments

13.2 Amgen

13.2.1 Amgen Company Information

13.2.2 Amgen Adalimumab Product Offered

13.2.3 Amgen Adalimumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Amgen Main Business Overview

13.2.5 Amgen Latest Developments

13.3 Sandoz

13.3.1 Sandoz Company Information

13.3.2 Sandoz Adalimumab Product Offered

13.3.3 Sandoz Adalimumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Sandoz Main Business Overview

13.3.5 Sandoz Latest Developments

13.4 Boehringer Ingelheim

13.4.1 Boehringer Ingelheim Company Information

13.4.2 Boehringer Ingelheim Adalimumab Product Offered

13.4.3 Boehringer Ingelheim Adalimumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Boehringer Ingelheim Main Business Overview

13.4.5 Boehringer Ingelheim Latest Developments

13.5 Mylan

13.5.1 Mylan Company Information

13.5.2 Mylan Adalimumab Product Offered

13.5.3 Mylan Adalimumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Mylan Main Business Overview

13.5.5 Mylan Latest Developments

13.6 Biogen

13.6.1 Biogen Company Information

13.6.2 Biogen Adalimumab Product Offered

13.6.3 Biogen Adalimumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Biogen Main Business Overview

13.6.5 Biogen Latest Developments

14 Research Findings and Conclusion

Table 1. Adalimumab Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Adalimumab Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Adalimumab

Table 4. Major Players of Adalimumab Biosimilar

Table 5. Global Adalimumab Sales by Type (2017-2022) & (K Units)

Table 6. Global Adalimumab Sales Market Share by Type (2017-2022)

Table 7. Global Adalimumab Revenue by Type (2017-2022) & ($ million)

Table 8. Global Adalimumab Revenue Market Share by Type (2017-2022)

Table 9. Global Adalimumab Sale Price by Type (2017-2022) & (USD/Unit)

Table 10. Global Adalimumab Sales by Application (2017-2022) & (K Units)

Table 11. Global Adalimumab Sales Market Share by Application (2017-2022)

Table 12. Global Adalimumab Revenue by Application (2017-2022)

Table 13. Global Adalimumab Revenue Market Share by Application (2017-2022)

Table 14. Global Adalimumab Sale Price by Application (2017-2022) & (USD/Unit)

Table 15. Global Adalimumab Sales by Company (2020-2022) & (K Units)

Table 16. Global Adalimumab Sales Market Share by Company (2020-2022)

Table 17. Global Adalimumab Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Adalimumab Revenue Market Share by Company (2020-2022)

Table 19. Global Adalimumab Sale Price by Company (2020-2022) & (USD/Unit)

Table 20. Key Manufacturers Adalimumab Producing Area Distribution and Sales Area

Table 21. Players Adalimumab Products Offered

Table 22. Adalimumab Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Adalimumab Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Adalimumab Sales Market Share Geographic Region (2017-2022)

Table 27. Global Adalimumab Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Adalimumab Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Adalimumab Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Adalimumab Sales Market Share by Country/Region (2017-2022)

Table 31. Global Adalimumab Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Adalimumab Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Adalimumab Sales by Country (2017-2022) & (K Units)

Table 34. Americas Adalimumab Sales Market Share by Country (2017-2022)

Table 35. Americas Adalimumab Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Adalimumab Revenue Market Share by Country (2017-2022)

Table 37. Americas Adalimumab Sales by Type (2017-2022) & (K Units)

Table 38. Americas Adalimumab Sales Market Share by Type (2017-2022)

Table 39. Americas Adalimumab Sales by Application (2017-2022) & (K Units)

Table 40. Americas Adalimumab Sales Market Share by Application (2017-2022)

Table 41. APAC Adalimumab Sales by Region (2017-2022) & (K Units)

Table 42. APAC Adalimumab Sales Market Share by Region (2017-2022)

Table 43. APAC Adalimumab Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Adalimumab Revenue Market Share by Region (2017-2022)

Table 45. APAC Adalimumab Sales by Type (2017-2022) & (K Units)

Table 46. APAC Adalimumab Sales Market Share by Type (2017-2022)

Table 47. APAC Adalimumab Sales by Application (2017-2022) & (K Units)

Table 48. APAC Adalimumab Sales Market Share by Application (2017-2022)

Table 49. Europe Adalimumab Sales by Country (2017-2022) & (K Units)

Table 50. Europe Adalimumab Sales Market Share by Country (2017-2022)

Table 51. Europe Adalimumab Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Adalimumab Revenue Market Share by Country (2017-2022)

Table 53. Europe Adalimumab Sales by Type (2017-2022) & (K Units)

Table 54. Europe Adalimumab Sales Market Share by Type (2017-2022)

Table 55. Europe Adalimumab Sales by Application (2017-2022) & (K Units)

Table 56. Europe Adalimumab Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Adalimumab Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Adalimumab Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Adalimumab Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Adalimumab Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Adalimumab Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Adalimumab Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Adalimumab Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Adalimumab Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Adalimumab

Table 66. Key Market Challenges & Risks of Adalimumab

Table 67. Key Industry Trends of Adalimumab

Table 68. Adalimumab Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Adalimumab Distributors List

Table 71. Adalimumab Customer List

Table 72. Global Adalimumab Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Adalimumab Sales Market Forecast by Region

Table 74. Global Adalimumab Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Adalimumab Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Adalimumab Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Adalimumab Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Adalimumab Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Adalimumab Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Adalimumab Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Adalimumab Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Adalimumab Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Adalimumab Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Adalimumab Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Adalimumab Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Adalimumab Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Adalimumab Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Adalimumab Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Adalimumab Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Adalimumab Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Adalimumab Revenue Market Share Forecast by Application (2023-2028)

Table 92. AbbVie Basic Information, Adalimumab Manufacturing Base, Sales Area and Its Competitors

Table 93. AbbVie Adalimumab Product Offered

Table 94. AbbVie Adalimumab Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 95. AbbVie Main Business

Table 96. AbbVie Latest Developments

Table 97. Amgen Basic Information, Adalimumab Manufacturing Base, Sales Area and Its Competitors

Table 98. Amgen Adalimumab Product Offered

Table 99. Amgen Adalimumab Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 100. Amgen Main Business

Table 101. Amgen Latest Developments

Table 102. Sandoz Basic Information, Adalimumab Manufacturing Base, Sales Area and Its Competitors

Table 103. Sandoz Adalimumab Product Offered

Table 104. Sandoz Adalimumab Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 105. Sandoz Main Business

Table 106. Sandoz Latest Developments

Table 107. Boehringer Ingelheim Basic Information, Adalimumab Manufacturing Base, Sales Area and Its Competitors

Table 108. Boehringer Ingelheim Adalimumab Product Offered

Table 109. Boehringer Ingelheim Adalimumab Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 110. Boehringer Ingelheim Main Business

Table 111. Boehringer Ingelheim Latest Developments

Table 112. Mylan Basic Information, Adalimumab Manufacturing Base, Sales Area and Its Competitors

Table 113. Mylan Adalimumab Product Offered

Table 114. Mylan Adalimumab Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 115. Mylan Main Business

Table 116. Mylan Latest Developments

Table 117. Biogen Basic Information, Adalimumab Manufacturing Base, Sales Area and Its Competitors

Table 118. Biogen Adalimumab Product Offered

Table 119. Biogen Adalimumab Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 120. Biogen Main Business

Table 121. Biogen Latest Developments

List of Figures

Figure 1. Picture of Adalimumab

Figure 2. Adalimumab Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Adalimumab Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Adalimumab Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Adalimumab Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Adalimumab

Figure 10. Product Picture of Adalimumab Biosimilar

Figure 11. Global Adalimumab Sales Market Share by Type in 2021

Figure 12. Global Adalimumab Revenue Market Share by Type (2017-2022)

Figure 13. Adalimumab Consumed in Adults

Figure 14. Global Adalimumab Market: Adults (2017-2022) & (K Units)

Figure 15. Adalimumab Consumed in Children

Figure 16. Global Adalimumab Market: Children (2017-2022) & (K Units)

Figure 17. Global Adalimumab Sales Market Share by Application (2017-2022)

Figure 18. Global Adalimumab Revenue Market Share by Application in 2021

Figure 19. Adalimumab Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Adalimumab Revenue Market Share by Company in 2021

Figure 21. Global Adalimumab Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Adalimumab Revenue Market Share by Geographic Region in 2021

Figure 23. Global Adalimumab Sales Market Share by Region (2017-2022)

Figure 24. Global Adalimumab Revenue Market Share by Country/Region in 2021

Figure 25. Americas Adalimumab Sales 2017-2022 (K Units)

Figure 26. Americas Adalimumab Revenue 2017-2022 ($ Millions)

Figure 27. APAC Adalimumab Sales 2017-2022 (K Units)

Figure 28. APAC Adalimumab Revenue 2017-2022 ($ Millions)

Figure 29. Europe Adalimumab Sales 2017-2022 (K Units)

Figure 30. Europe Adalimumab Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Adalimumab Sales 2017-2022 (K Units)

Figure 32. Middle East & Africa Adalimumab Revenue 2017-2022 ($ Millions)

Figure 33. Americas Adalimumab Sales Market Share by Country in 2021

Figure 34. Americas Adalimumab Revenue Market Share by Country in 2021

Figure 35. United States Adalimumab Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada Adalimumab Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico Adalimumab Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil Adalimumab Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC Adalimumab Sales Market Share by Region in 2021

Figure 40. APAC Adalimumab Revenue Market Share by Regions in 2021

Figure 41. China Adalimumab Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan Adalimumab Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea Adalimumab Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia Adalimumab Revenue Growth 2017-2022 ($ Millions)

Figure 45. India Adalimumab Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia Adalimumab Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe Adalimumab Sales Market Share by Country in 2021

Figure 48. Europe Adalimumab Revenue Market Share by Country in 2021

Figure 49. Germany Adalimumab Revenue Growth 2017-2022 ($ Millions)

Figure 50. France Adalimumab Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK Adalimumab Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy Adalimumab Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia Adalimumab Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa Adalimumab Sales Market Share by Country in 2021

Figure 55. Middle East & Africa Adalimumab Revenue Market Share by Country in 2021

Figure 56. Egypt Adalimumab Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa Adalimumab Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel Adalimumab Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey Adalimumab Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Adalimumab Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of Adalimumab in 2021

Figure 62. Manufacturing Process Analysis of Adalimumab

Figure 63. Industry Chain Structure of Adalimumab

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles